Left atrial appendage closure - ready for widespread clinical use?

Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11120%2F20%3A43920643" target="_blank" >RIV/00216208:11120/20:43920643 - isvavai.cz</a>
Result on the web
<a href="https://doi.org/10.4244/EIJV16I9A129" target="_blank" >https://doi.org/10.4244/EIJV16I9A129</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.4244/EIJV16I9A129" target="_blank" >10.4244/EIJV16I9A129</a>

Result language
angličtina
Original language name
Left atrial appendage closure - ready for widespread clinical use?
Original language description
Stroke remains a major cause of death and disability. Despite the recent advances in acute stroke treatment, the most effective way to avoid stroke-related mortality and disability is not treatment, but prevention. As most severe ischaemic strokes are related to cardioembolism in patients with atrial fibrillation (AF), the cornerstone of successful stroke prevention is oral anticoagulation (OAC). Long-term OAC carries an inherent risk of bleeding complications. The longer OAC is used, the higher is the cumulative risk of bleeding. In most patients with AF, OAC should be given permanently unless severe bleeding occurs.
Czech name
—
Czech description
—

Project
—
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Publication year
2020
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Similar results(10)